TGA gives CSL local vaccine manufacturing approval
The Therapeutic Goods Administration on Sunday approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia by CSL’s Seqirus vaccine division. This follows on from the 16 February 2021 approval by TGA of the overseas-manufactured AstraZeneca vaccine. The delay in both approvals is part of criticism of the federal government’s vaccine rollout – see separate…